← Leaderboards
Ram Sasisekharan
Massachusetts Institute Of Technology
$26,464,733
Attributed
$28,053,257
Total exposure
13
Grants
11
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.9M · FY2005–19$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$27,053,257 · 12
FDA$1,000,000 · 1
By mechanism
R01$10,914,009 · 5
U54$8,250,300 · 1
R37$3,894,337 · 1
R24$1,903,914 · 1
RC2$1,273,134 · 1
U01$1,000,000 · 1
Top collaborators
- Rahul Raman3 shared
- Robert J Linhardt2 shared
Most similar at Massachusetts Institute Of Technology
Same institution · by research overlap
- John M Essigmann$37,602,684
- Timothy M Swager$4,533,963
- Robert S Langer$47,407,448
- John S. Wishnok$7,632,021
- Daniel Leif Migdow Suess$3,411,836
Others in their field
Top investigators on “Proteins”
- David Heimbrook · Leidos Biomedical Research, Inc.$354,061,551
- Randall J Bateman · Washington University$187,292,085
- Paul S. Aisen · Cognition Therapeutics, Inc.$175,382,342
- Reisa A. Sperling · Banner Health$145,046,481
- Barton F Haynes · Duke University$136,029,850
- Joseph L Goldstein · University Of Texas Sw Med Ctr/Dallas$102,433,280
Research focus
ProteinsStructurePolysaccharidesGrantStructure-Activity RelationshipComplexTechnologyDatabasesBaseInformaticsTissuesData SetBiological ProcessBiochemicalGlycosaminoglycansResearch PersonnelBiologicalAreaMucopolysaccharidesInternationalHeparinProgramsBioinformaticsAnalytical Tool
Grant awards (65)
Structure-Function Relationship of Glycosaminoglycans$390,000
R37 · FY2019 · GM · contact PI
Characterization and Development of a Cross Spectrum Anti-Dengue Antibody$750,000
R01 · FY2018 · AI · contact PI
Structure-Function Relationship of Glycosaminoglycans$390,000
R37 · FY2018 · GM · contact PI
Characterization and Development of a Cross Spectrum Anti-Dengue Antibody$750,000
R01 · FY2017 · AI · contact PI
Structure-Function Relationship of Glycosaminoglycans$390,000
R37 · FY2017 · GM · contact PI
Characterization and Development of a Cross Spectrum Anti-Dengue Antibody$750,000
R01 · FY2016 · AI · contact PI
Structure-Function Relationship of Glycosaminoglycans$390,000
R37 · FY2016 · GM · contact PI
Integrated approach to determine equivalence in complex drug mixtures$200,000
U01 · FY2016 · FD · contact PI
Characterization and Development of a Cross Spectrum Anti-Dengue Antibody$750,000
R01 · FY2015 · AI · contact PI
Structure-Function Relationship of Glycosaminoglycans$390,000
R37 · FY2015 · GM · contact PI
Integrated approach to determine equivalence in complex drug mixtures$200,000
U01 · FY2015 · FD · contact PI
Characterization and Development of a Cross Spectrum Anti-Dengue Antibody$750,000
R01 · FY2014 · AI · contact PI
Integrated approach to determine equivalence in complex drug mixtures$600,000
U01 · FY2014 · FD · contact PI
Structure-Function Relationship of Glycosaminoglycans$380,211
R37 · FY2014 · GM · contact PI
Structure-Function Relationship of Glycosaminoglycans$50,000
R37 · FY2014 · GM · contact PI
Legacy Informatics Resources for Glycomics$520,404
R24 · FY2013 · GM · contact PI
Structure-Function Relationship of Glycosaminoglycans$368,329
R37 · FY2013 · GM · contact PI
Legacy Informatics Resources for Glycomics$635,580
R24 · FY2012 · GM · contact PI
Structure-Function Relationship of Glycosaminoglycans$383,444
R37 · FY2012 · GM · contact PI
Legacy Informatics Resources for Glycomics$747,930
R24 · FY2011 · GM · contact PI
Structure-Function Relationship of Glycosaminoglycans$385,817
R37 · FY2011 · GM · contact PI
Investigating Complex Glycans on Biological Surfaces$193,980
R21 · FY2011 · AI · contact PI
Core--Biolnformatics$1,725,147
U54 · FY2010 · GM · contact PI
Characterization of Anticoagulant Heparin and Related Polysaccharides$552,006
RC2 · FY2010 · HL · contact PI
Structure-Function Relationship of Glycosaminoglycans$376,536
R37 · FY2010 · GM · contact PI
Investigating Complex Glycans on Biological Surfaces$238,609
R21 · FY2010 · AI · contact PI
Enzymatic Degradation of Glycosaminoglycans$27,000
R01 · FY2010 · GM · contact PI
Core--Biolnformatics$1,742,573
U54 · FY2009 · GM · contact PI
Characterization of Anticoagulant Heparin and Related Polysaccharides$721,128
RC2 · FY2009 · HL · contact PI
Enzymatic Degradation of Glycosaminoglycans$352,229
R01 · FY2009 · GM · contact PI
Core--Biolnformatics$1,742,604
U54 · FY2008 · GM · contact PI
Enzymatic Degradation of Glycosaminoglycans$383,137
R01 · FY2008 · GM · contact PI
Structure-Activity Relationships of LMWHs$310,340
R01 · FY2008 · HL · contact PI
Enzymatic Degradation of Glycosaminoglycans$46,148
R01 · FY2008 · GM · contact PI
Core--Biolnformatics$1,749,665
U54 · FY2007 · GM · contact PI
Enzymatic Degradation of Glycosaminoglycans$320,757
R01 · FY2007 · GM · contact PI
Structure-Activity Relationships of LMWHs$310,340
R01 · FY2007 · HL · contact PI
Enzymatic Degradation of Glycosaminoglycans$30,918
R01 · FY2007 · GM · contact PI
Enzymatic Degradation of Glycosaminoglycans$25,000
R01 · FY2007 · GM · contact PI
Core--Biolnformatics$1,290,311
U54 · FY2006 · GM · contact PI
Structure-Activity Relationships of LMWHs$319,609
R01 · FY2006 · HL · contact PI
Molecular Principles of FGF-HSGAG Interactions$236,977
R01 · FY2006 · HL · contact PI
Enzymatic Degradation of Glycosaminoglycans$232,589
R01 · FY2006 · GM · contact PI
Oligosaccharides Regulating Cell Function$111,737
R21 · FY2006 · GM · contact PI
Sequence Analysis of Glycosaminoglycans$95,970
R01 · FY2006 · GM · contact PI
Structure-Activity Relationships of LMWHs$342,166
R01 · FY2005 · HL
Sequence Analysis of Glycosaminoglycans$289,907
R01 · FY2005 · GM
Molecular Principles of FGF-HSGAG Interactions$242,680
R01 · FY2005 · HL
Database for Glycan Structures$158,812
R41 · FY2005 · GM
Oligosaccharides Regulating Cell Function$114,425
R21 · FY2005 · GM
Sequence Analysis of Glycosaminoglycans$289,907
R01 · FY2004 · GM
Heparin like Glycosaminoglycan Oligosaccharides$274,730
R01 · FY2004 · CA
Molecular Principles of FGF-HSGAG Interactions$242,680
R01 · FY2004 · HL
Sequence Analysis of Glycosaminoglycans$289,907
R01 · FY2003 · GM
Heparin like Glycosaminoglycan Oligosaccharides$274,730
R01 · FY2003 · CA
Molecular Principles of FGF-HSGAG Interactions$257,680
R01 · FY2003 · HL
Sequence Analysis of Glycosaminoglycans$300,579
R01 · FY2002 · GM
Heparin like Glycosaminoglycan Oligosaccharides$274,730
R01 · FY2002 · CA
FGF OLIGOMERIZATION MODULATED BY GLYCOSAMINOGLYCANS$243,351
R01 · FY2002 · HL
Heparin like Glycosaminoglycan Oligosaccharides$274,177
R01 · FY2001 · CA
FGF OLIGOMERIZATION MODULATED BY GLYCOSAMINOGLYCANS$236,447
R01 · FY2001 · HL
ENZYMATIC DEGRADATION OF GLYCOSAMINOGLYCANS$189,040
R01 · FY2001 · GM
ENZYMATIC DEGRADATION OF GLYCOSAMINOGLYCANS$35,000
R01 · FY2001 · GM
FGF OLIGOMERIZATION MODULATED BY GLYCOSAMINOGLYCANS$229,750
R01 · FY2000 · HL
ENZYMATIC DEGRADATION OF GLYCOSAMINOGLYCANS$185,534
R01 · FY2000 · GM